Cohan, Stanley http://orcid.org/0000-0002-9568-346X
Kumar, Jinender
Arndorfer, Stella
Zhu, Xuelian
Zivkovic, Marko
Tencer, Tom
Article History
Accepted: 10 March 2021
First Online: 13 April 2021
Declarations
:
: This study was supported by Bristol Myers Squibb, Princeton, NJ. Bristol Myers Squibb was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. Publication fees were paid by Bristol Myers Squibb. The authors directed and are fully responsible for all content and editorial decisions for this manuscript.
: SC: Advisory board – AbbVie, Biogen, Novartis, Pear Therapeutics, Roche Genentech, and Sanofi Genzyme; speaker – Biogen, Novartis, Roche Genentech, and Sanofi Genzyme; grant/research support to SC employer Providence Brain and Spine Institute – AbbVie, Adamas, Altios, Biogen, EMD Serono, MedDay, NARCRMS, Novartis, Providence St. Vincent Foundation, Roche Genentech, and Sanofi Genzyme; consultant – AbbVie, Bristol Myers Squibb. SA, XZ & MZ: Employment – Genesis Research (Genesis Research provided consulting services to Celgene, a Bristol Myers Squibb). TT & JK: Employment –a Bristol Myers Squibb company.
: Not applicable.
: Not applicable.
: Not applicable.
: Data requests may be submitted to Celgene, a Bristol Myers Squibb company, at ExternalRef removed.
: Not applicable.
: MZ, SA, and XZ were responsible for the study design and data analysis. All authors were the study investigators, interpreted the data, and prepared, reviewed, revised, and gave approval for publication of the manuscript.